Sudhir Srivastava

Chairman, CEO & Founder, SS Innovations International
· tracked since Jul 2026
Calls
1
Win Rate
0.0%
return
-3.9%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 1
Best Calls
No live winners yet
Worst Calls
SSII Long -3.9%
Most Mentioned
SSII ×1
Recent Calls
Win Rate 0% Long 1 Short 0
Win Rate
7d 100%
30d 0%
90d —
Average Return -3.9% Long Return -3.9% Short Return -
Average Return
7d +12.4%
30d -1.4%
90d —
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
SSII SS Innov... SS Innovations Inte...
Long
Jul 23
$3.55
-3.9%
Robotic surgery disruptor with FDA catalyst.
SS Innovations' surgical robot is commercially validated in India, offers capabilities beyond da Vinci at less than half the price, has strong interest from major U.S. hospitals, and is awaiting FDA approval expected next year, which will unlock significant U.S. revenue and improve the currently depressed stock valuation.
MedTech
YOUTUBE
Showing 1 of 1 calls · sorted by mentions

Sudhir Srivastava has 1 trade ideas tracked on Buzzberg across 1 tickers since July 2026. Most covered: SSII.